Merck Serono is the division for innovative prescription pharmaceuticals of Merck, a global pharmaceutical and chemical group. Headquartered in Geneva, Switzerland, Merck Serono discovers, develops, manufactures and markets innovative small molecules and biopharmaceuticals to help patients with unmet medical needs. Its North American business operates in the United States and Canada as EMD Serono. Merck Serono has leading brands serving patients with cancer (Erbitux®), multiple sclerosis (Rebif®), infertility (Gonal-f®), endocrine and cardiometabolic disorders (Glucophage®, Concor®, Saizen®, Serostim®), as well as psoriasis (Raptiva®). With an annual R&D investment of around €1 billion, Merck Serono is committed to growing its business in specialist-focused therapeutic areas including neurodegenerative diseases, oncology, fertility and endocrinology, as well as new areas potentially arising out of research and development in autoimmune and inflammatory diseases.
View Top Employees from Merck SeronoWebsite | http://www.merckgroup.com |
Revenue | $25 million |
Employees | 1 (1 on RocketReach) |
Address | 25 Frenchs Forest Rd East, Frenchs Forest, New South Wales 2086, AU |
Phone | +61 2 8977 4100 |
Industry | Pharmaceuticals, Healthcare |
Competitors | Birchmere Ventures, CoLucid Pharmaceuticals, Inc, Elcelyx Therapeutics Inc., PRAGMA Therapeutics, XTL Biopharmaceuticals Ltd. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Merck Serono employee's phone or email?
The Merck Serono annual revenue was $25 million in 2024.
1 people are employed at Merck Serono.
Merck Serono is based in Frenchs Forest, New South Wales.
The NAICS codes for Merck Serono are [325, 3254, 32].
The SIC codes for Merck Serono are [28, 283].